REGN vs VRTX: side-by-side analysis

Where REGN and VRTX sit on fair value

REGN's composite fair-value range is $917–$1505 (midpoint $1210), versus a current price of $715. VRTX is one of REGN's closest sector neighbours and shows up directly in the peer table inside our full report, with a market-cap of $109.1B, P/E of 19.9x, EV/EBITDA of 20.8x, and an operating margin of 38.1%. The cross-read is editorial: same archetype expectations, same discount-rate philosophy, different operating model.

Both names are evaluated under the same six-factor decision overlay (customer value, unit economics, TAM, moat durability, risk profile, valuation) so comparing them is apples-to-apples rather than headline-multiple-to-headline-multiple. The rating differential between REGN and VRTX is driven by where each lands across those six axes, not by who looks "cheaper" on a single screen.

Where they actually differ

REGN is classified as a mature compounder stock; the archetype dictates our deceleration curve, terminal multiple, and probability weights. VRTX, depending on its own archetype, will have its own calibration — and that is precisely why simple peer multiples can mislead. A 13.3× forward P/E with a PEG of 1.48 is not the same on REGN as it is on VRTX unless they share the same growth profile, capital intensity, and moat half-life.

REGN's moat assessment is 9/10, and the full moat section in the report covers the source (network effects, switching costs, intangibles, scale, etc.) plus the timeline of any threats. The cross-read against VRTX should focus on which company's economic profit (ROIC minus WACC) is wider AND more durable — that is the variable that dominates long-run total return between two same-sector names.

Which one wins on each dimension

Valuation: REGN looks meaningfully undervalued versus our fair-value midpoint. The full report's peer table compares REGN and VRTX directly on P/E, PEG, EV/EBITDA, ROE, and operating margin. Risk: the bear case for REGN is bound by the kill-scenarios list in Section 2; the equivalent for VRTX would need its own report. We do not co-rate two companies on a single page.

Capital allocation and growth runway typically separate same-sector pairs more than the headline numbers suggest. The full report's capital-allocation paragraph and TAM analysis are the lenses we recommend before deciding whether REGN or VRTX is the better expression of the same theme.

Bottom line — REGN or VRTX?

Our rating for REGN is Strong Buy with a 88/100 confidence score; the rating already accounts for the relative-value information embedded in the peer table that includes VRTX. The cross-read is most useful when the two companies are real substitutes in a portfolio (same factor exposure, same end markets, same archetype) — otherwise the comparison is theatre.

For the full evidence on REGN, including the explicit peer multiples versus VRTX and the rest of the comp set, see the canonical report at /stocks/regn/analysis. For VRTX's standalone report, see /stocks/vrtx/analysis.

Frequently asked questions